Stage IIIB Cutaneous Melanoma AJCC v7 Completed Phase 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0091048 (Stage IIIB Cutaneous Melanoma AJCC v7)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01807182Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic MelanomaTreatment